Tags : Vanderbilt Center for Neuroscience Drug Discovery

Pharma

Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) to Collaborate with

Shots VCNDD and BI enters into two agreement for the development and commercialization of two small molecules targeting GPCRs for neuropsychiatric disorders The focus of the agreement is to develop and expand therapies for neurological conditions including maladaptive brain circuitry GPCRs(G-protein coupled receptors) are protein involved in regulation of brain circuit functions targeting schizophrenia, further […]Read More